Endocrine, Metabolic & Immune Disorders - Drug Targets

Journal Impact Factor: 2.0
Scopus Cite Score: 4.4

Indexed in: Scopus, SCI Expanded, MEDLINE/PubMed

View All
Aims and Scope:

This journal is devoted to full-length/mini-reviews and original articles based on experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to the effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and microbiome composition are welcome. The journal’s scope also covers neuroendocrinology, reproductive endocrinology, hormone secretion, and their effects on different organs.

Endocrine, Metabolic & Immune Disorders - Drug Targets is an international, peer-reviewed open access journal on all aspects of endocrine, metabolic, and immune disorders, published continuously by Bentham Science Publishers.
Read more...
Start Submission Button Icon

Editor-in-Chief:

  • Emilio Jirillo Department of Basic Medical Sciences Neuroscience and Sensory Organs
    University of Bari “Aldo Moro”
    Bari
    Italy

ISSN: 2212-3873

Special Issues With Active Call for Papers

Submission closes on: Aug 21, 2026
Advances in Targeting the Gut–Microbiota–Immune Axis in Metabolic Disorders

This special issue aims to explore the rapidly evolving field of the gut–microbiota–immune axis and its critical role in the development, progression, and treatment of metabolic disorders. By highlighting current research and innovative therapeutic strategies, the issue seeks to advance our understanding of how modulating gut microbiota and immune interactions can offer new avenues for managing metabolic disorders. see more

Impact Factor: 2.0
Guest Editor(s): Dr. Manish Gautam
Co-Guest Editor(s): Phool Chandra,Sandip Mondal
Start Submission
Submission closes on: Feb 22, 2026
Advances in Therapeutic Strategies: Bridging Endocrine, Metabolic, Cancer and Immune Disorders for Precision Medicine.

The intricate interplay between endocrine, metabolic, and immunological disorders, addressing the challenges posed by their overlapping pathophysiology. With a focus on diseases such as diabetes, obesity, autoimmune thyroid conditions, and systemic inflammatory disorders, it highlights the transformative potential of precision medicine. Advances in genomics, transcriptomics, proteomics, and metabolomics are uncovering novel biomarkers and therapeutic targets, enabling personalized treatment strategies tailored to individual molecular profiles. The issue showcases cutting-edge research and translational initiatives, emphasizing innovative therapies... see more

Impact Factor: 2.0
Guest Editor(s): Dr. H. K. Verma
Co-Guest Editor(s): Dr. Manish Verma,Dr. Areena Siddiqui
Start Submission